Compare Injective (INJ) vs Raydium (RAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Injective vs Raydium — how do they compare? Injective trades at Rp92,698 (market cap Rp9,29T, Rp1,76T 24h volume), while Raydium trades at Rp12,535 (market cap Rp3,36T, Rp218,63M 24h volume). The key difference: Injective is far larger — about 2.8× Raydium's market cap, and Raydium's supply is capped (269,3M / 555M RAY (49%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Raydium for 24 Days on average.
| INJ | RAY | |
|---|---|---|
Market Cap | Rp9,29T | Rp3,36T |
Volume (24h) | Rp1,76T | Rp218,63M |
Circulating Supply | 100M INJ | 269,3M / 555M RAY (49%) |
Typical Hold Time | 36 Days | 24 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Raydium (RAY) trades at Rp12,568, showing neutral technical signals with bullish moving averages but neutral oscillators. The token holds a market cap of Rp3.36T with 49% of its max supply circulating. Recent milestones include surpassing Rp1,000T in trading volume after listings on Robinhood and Revolut, and enabling tokenized SpaceX stock trading on Solana, boosting its ecosystem utility.
Outlook is cautiously optimistic due to growing exchange support and protocol innovation, but risks include high volatility and regulatory uncertainty. Key support lies at Rp11,834, with resistance at Rp12,514. Investors should monitor on-chain activity and broader crypto market trends for directional cues.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Injective
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →About Raydium
Raydium (RAY) is an automated market maker (AMM) and liquidity provider built on the Solana blockchain for the Serum decentralized exchange (DEX). Unlike any other AMMs, Raydium provides on-chain liquidity to a central limit orderbook meaning that funds deposited into Raydium are converted into limit orders which sit on Serum’s orderbooks.
Read more on RAY →
